Graft flow as a predictor of thrombosis in hemodialysis grafts  by Bosman, Peter J. et al.
Graft flow as a predictor of thrombosis in hemodialysis grafts
PETER J. BOSMAN, FRANS T.J. BOEREBOOM, BERT C. EIKELBOOM, HEIN A. KOOMANS,
and PETER J. BLANKESTIJN
Departments of Nephrology and Vascular Surgery, University Hospital Utrecht, The Netherlands
Graft flow as a predictor of thrombosis in hemodialysis grafts.
Background. The effort to reduce the incidence of graft throm-
bosis is mainly based on predicting venous stenosis by measuring
venous drip chamber pressures. In this study we evaluated
whether graft flow measurements, using an ultrasound dilution
technique, would be of additional value to identify patients at risk
for thrombosis.
Methods. In fifty consecutive patients with a bridge graft we
measured graft flow and venous drip chamber pressure at a
dialyzer blood flow of 200 ml/min. The results of these flow
measurements were not used for selection of patients, nor for a
diagnostic or therapeutic procedure. All thrombotic events and
(radiological or surgical) interventions were registered.
Results. A total of 17 patient-years were analyzed. In 17 patients
an intervention was done, and in 18 patients thrombosis occurred.
The incidence rate of thrombosis was higher in patients with a
flow , 600 ml/min (N 5 13) compared to patients with a flow .
600 ml/min (N 5 37; rate ratio 7.2; 95% CI, range 2.84 to 18.24,
P , 0.001). In 4 patients with a flow , 600 ml/min an intervention
was done within the first two months after the flow measurement.
In the remaining 9 patients, 6 grafts thrombosed within this
period. Five interventions were done in patients with a flow . 600
ml/min. In the remaining 32 patients only two developed sponta-
neous thrombosis. Remarkably, venous drip chamber pressure
measurements did not discriminate between patients with graft
flow . or , 600 ml/min, and showed a wide range in patients who
developed spontaneous thrombosis within two months.
Conclusion. We suggest that graft flow measurements are
helpful in selecting patients at risk for graft thrombosis.
Graft thrombosis is usually associated with the presence
of one or more stenoses, which are typically located in the
venous outflow tract [1–4]. The common policy of graft
surveillance is directed towards detecting these stenoses
[5–9]. For this purpose venous pressures measured by the
dialysis machine are widely advocated and have indeed
been shown to improve patient outcome [10, 11]. However,
the risk for thrombosis is probably not determined by the
luminal reduction per se, but by its combined occurrence
with a low graft flow. Several studies have indicated that a
flow below 600 to 800 ml/min indicates imminent throm-
bosis [12–17]. This approach has not been widely accepted
because the methodology for assessment of graft flow is
either invasive, highly operator dependent and/or expen-
sive. The recent introduction of the ultrasound dilution
technique has made it possible to assess graft flow reliably
and relatively easily [18, 19].
In a recent cross-sectional study, we showed that by using
venous pressures patients with outflow stenosis may be
selected accurately. However, we also showed that a high
venous pressure did not necessarily coincide with low graft
flow and, even more important, that not all grafts with low
flow showed high venous pressures [20]. It was likely that
patients with an arterial inflow or midgraft stenosis and
patients with overall poor quality of the graft were missed
by venous pressure measurements. This may contribute to
the fact that when venous pressure measurements are used
to select patients for corrective interventions spontaneous
graft thrombosis still occurs [10, 11].
Based upon these considerations, we hypothesized that
the measurement of graft blood flow would be of additional
value to venous pressure measurements in the identifica-
tion of patients with an increased risk for graft thrombosis.
In the present study we tested this hypothesis by measuring
flow in patients who were monitored by venous pressure
measurements.
METHODS
In our hospital, patients with a bridge graft are moni-
tored in an effort to prevent thrombosis. When the venous
pressures at a dialyzer flow of 200 ml/min are consistently
elevated (.135 to 140 mm Hg), when prescribed dialyzer
blood flow cannot be obtained (200 to 300 ml/min), or when
difficulties in graft needling are encountered, patients are
referred for angiography. Usually the diagnostic procedure
is followed by a radiological or surgical intervention. In the
current study, in addition to our normal procedure, 50
consecutive patients also had flow measurements recorded
by means of an ultrasound dilution technique. The results
of these flow measurements were explicitly not used for
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selection of patients for a diagnostic procedure or thera-
peutic intervention.
After the flow measurements the grafts were observed
and all thrombotic events and interventions were recorded.
The follow up was at least two months unless a thrombotic
event occurred or an intervention was performed. Two
months was chosen since such a period was considered to
be a clinically feasible and reasonable interval for repeat
flow measurements in clinical surveillance of dialysis grafts.
The data were collected prospectively by an investigator
who was not involved in proces of clinical decision making.
Measurements
Graft flow was measured with the Transonic Hemodial-
ysis Monitor (Transonic Systems Inc., Ithaca, NY, USA).
The theoretical background, bench validation and in vivo
validation are described in detail in previous papers [18,
19]. Flow determinations consisted of five single measure-
ments within one dialysis session, which were averaged. All
measurements were done during a fixed dialyzer blood flow
of 200 ml/min. Ultrafiltration was turned off three minutes
before the start of the measurements, in order to avoid the
effect of hemoconcentration during the measurements.
Subsequently, pressure measurements were performed
by the Gambro AK100 dialysis machine using a standard
Gambro tubing set and two 15Gx25 mm Gambro needles.
With this device venous drip chamber pressure (VP) of the
circuit can be monitored continuously on a digital display.
Venous pressure was assessed at a dialysis machine blood
flow of 200 ml/min (VP200). The results were the averages
of 10 subsequent readings on the display. All measure-
ments were done in a standardized way with the access at
the level of the venous drip chamber. Both flow and
pressure measurements were performed within the first 30
minutes of the same dialysis session.
Data analysis
The available literature using the same [16] or other
[12–15, 17] methods for access flow measurement indicate
that grafts showing a flow below 600 to 800 ml/min are to be
considered at risk for thrombosis. Therefore, for the
present analysis we studied both 600 ml/min and 800
ml/min as a threshold level. The patency rate until throm-
bosis was defined as the percentage of grafts that had not
thrombosed at the end of follow up. Thrombosis was the
end-point of interest in this study. Patients who underwent
an elective intervention were censored. The patency rate
until thrombosis was calculated and compared for the
groups created after division of the patients using the flow
thresholds. The incidence rates of thrombosis and of inter-
ventions were calculated as the number of events per
patient-year.
Patency rates were calculated with Kaplan Meier analy-
sis. Differences in the patency rates were tested with Log
rank test. Differences between incidence rates of thrombo-
sis and of intervention were calculated with Poisson regres-
sion analysis. Mann-Whitney U-test was used to compare
the distribution of a variable between two non related
groups. A P value , 0.05 was considered significant.
Results are mean 6 SD, unless stated otherwise.
RESULTS
All patients (14 male) had an arteriovenous bridge graft
(19 polytetrafluoroethylene grafts and 31 denatured homol-
ogous veins grafts) in the forearm, that is, a looped graft
between the brachial artery and cephalic vein, or, in three
cases, a straight graft from the radial artery to the cephalic
vein.
The mean graft flow was 967 6 584 ml/min (range 89 to
2745, median 813 ml/min) and the mean VP200 was 116 6
31 mm Hg (range 57 to 203, median 116 mm Hg). Results
of venous pressure and flow measurements of PTFE and
Table 1. Number and incidence of thrombotic events and interventions
in two groups divided by a threshold of 600 ml/min for flow.
Flow ml/min
P value#600 .600
Follow-up (years) 1.7 15.3
N Total 13 37
No events 0 15
Intervention 5 12
Thrombosis 8 10
Incidence (/py)
Intervention 2.9 0.9 0.012
Thrombosis 4.7 0.7 , 0.001
Abbreviations are: N, number of patients; Incidence (/py), events per
patient year.
Fig. 1. Life table of the patency until thrombosis in grafts with a flow <
600 ml/min (dashed line) and grafts with a flow > 600 ml/min (solid line)
(P < 0.001).
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vein grafts showed no significant differences. The total
follow-up was 17 patient-years. In 13 patients a radiological
and in four patients a surgical intervention was performed.
The radiological procedures were angioplasties of the
venous anastomosis in 12 cases and of an upper arm venous
stenosis in one case. In three cases a stenosis upstream of
the venous needle cannulation site was treated as well. The
four surgical interventions were angioplasties of the venous
anastomosis in two cases, of the arterial anastomosis in one
case and an aneurysm resection combined with a revision of
the arterial anastomosis in one case. Thirteen of these
patients had high venous pressures, and the remaining
patients had either difficulties with cannulation or with
obtaining adequate dialyzer blood flow. In 18 patients
thrombosis occurred.
Patency rates until thrombosis and the relative risk were
calculated using a threshold of 600 ml/min. The patency
rates in patients with a flow , 600 ml/min (N 5 13) were
lower than in patients with a flow . 600 ml/min (N 5 37;
P , 0.001; Fig. 1), despite a higher incidence for interven-
tions in the low flow group (Table 1). The rate ratio of
thrombosis was 7.20 (95% CI, 2.84 to 18.24, P , 0.001) for
the patients having a flow , 600 ml/min. When using a
threshold of 800 ml/min, the patency rates in the patients
with a flow , 800 ml/min (N 5 22) compared with a flow .
800 ml/min (N 5 28) were lower as well, but this difference
was of borderline significance (P 5 0.06). The rate ratio of
thrombosis was 2.15 (95% CI, 0.85 to 5.44, P 5 0.11) for the
patients having a flow , 800 ml/min. For further analysis
the flow threshold of 600 ml/min was used.
In the 13 patients with a graft flow , 600 ml/min, the
mean flow was 334 6 142 ml/min, and the VP200 was 121 6
40 mm Hg (Fig. 2). An intervention was made in 5 patients
(2.9 per patient-year; Table 1). In the remaining 8 patients
a spontaneous graft thrombosis occurred (4.7 per patient-
year) after a median follow up of 22 days (range 3 to 205
days). In the 37 patients with a graft flow . 600 ml/min, the
mean graft flow was 1192 6 511 ml/min, and the VP200 was
114 6 29 mm Hg (Fig. 2). The mean VP200 was not
significantly lower in these patients compared to the pa-
tients with a flow , 600 ml/min (Fig. 2). An intervention
was made in 12 patients (0.9 per patient-year; Table 1). In
15 patients no thrombosis occurred or intervention was
done. Ten patients experienced spontaneous graft throm-
bosis (0.7 per patient-year) after a median follow up of 76
days (range 3 to 431 days).
We also analyzed the events occurring within two months
of the flow measurements. This period was chosen as a
clinically feasible and reasonable interval for repeat flow
measurements. In the 13 patients with a graft flow , 600
ml/min, an intervention was made in four cases. Of the
remaining nine patients, six developed spontaneous throm-
bosis. Thus, a total of 77% in these 13 patients either
underwent an intervention or developed spontaneous
thrombosis within two months of the flow measurement. As
shown in Figure 2 (arrows), of the patients developing
spontaneous thrombosis only two were discriminated by the
VP200 measurements.
In the 37 patients with a graft flow . 600 ml/min, an
intervention was made in 5 cases. Of the remaining 32
patients, two developed spontaneous thrombosis. Therefore,
19% of these 37 patients either underwent an intervention or
Fig. 2. Individual results of flow (A) and
venous pressure at a blood flow of 200 ml/min
(VP200) (B) measurements in patients with a
flow < 600 ml/min (N 5 13) and patients with
a flow > 600 ml/min (N 5 37). Arrows indicate
patients with a thrombotic event within 2
months after the measurements.
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developed spontaneous thrombosis. The latter two cases were
neither predicted by a critically elevated VP200, nor by a low
graft flow (Fig. 2, arrows).
In all eight patients developing spontaneous thrombosis,
six (75%) were discriminated by a graft flow of , 600
ml/min. Two of these eight patients had high VP200, but
thrombosis occurred before an intervention was done. Six
had a VP200 of , 135 to 140 mm Hg (Fig. 2B).
DISCUSSION
The main conclusion of this study is that in patients
having normal VP200 a substantial number remain at
increased risk for graft thrombosis. These patients can
often be identified by their low graft flow.
Venous pressure measured intragraft or by the dialysis
machine are widely advocated as variables for access sur-
veillance [5–9]. Indeed, in two studies it was shown that
patients who were selected using either VP200 [10] or
venous pressure at zero dialyzer blood flow [11] generally
showed a venous outflow stenosis. More importantly it was
shown in these two studies that when the selected patients
were referred for angiography and stenoses were treated,
the thrombosis rate could be diminished [10, 11].
In a recent cross-sectional study [20], we confirmed that
patients who have a venous outflow stenosis on average
show a higher venous pressure than those without stenosis.
However, the venous pressure in the two groups showed
substantial overlap and no correlation was found between
VP200 and spontaneous graft flow. In other words, a high
venous pressure did not necessarily coincide with a low
graft flow, which in some studies was found to indicate
imminent thrombosis [12–17]. In addition, we also showed
that not all grafts with low flow showed high venous
pressure. Patients with arterial inflow or midgraft stenosis
or patients with overall poor quality of the supplying
arterial system are likely to be missed by venous pressure
measurements. Based on these considerations we hypoth-
esized that patients at risk for thrombosis may be identified
using flow measurements who are not identified using
venous pressure measurements. The results of the present
study strongly suggest that the above-mentioned hypothesis
indeed is correct. Admittedly, we cannot exclude the pos-
sibility that the diagnostic value of VP200 may have in-
creased if readings from three or more consecutive treat-
ments were used.
Graft thrombosis occurred especially in those patients
showing a flow , 600 ml/min. A higher incidence rate of
thrombosis per patient year was found in this low flow
group. Further, these thrombotic events occurred relatively
early after the flow measurement. Within two months after
the flow measurements an intervention was done in 4
patients with a flow , 600 ml/min. In the remaining 9
(untreated) patients, thrombosis occurred in 6 grafts
(67%). In contrast, in the 32 untreated patients in the
group with a flow . 600 ml/min, thrombosis occurred in
only 2 grafts (6%) within this period. This indicates that
flow measurements are indeed of clinical value in identify-
ing patients at risk for thrombosis. Therefore, we believe
that periodic assessment of graft flow, for instance every
two months, will enable us to reduce the thrombosis rate.
With the present data it is not yet possible to outline the
optimal way in which graft flow measurements can be
implemented in the graft surveillance policy. It should be
considered that three of the nine patients (33%) with a
graft flow below 600 ml/min who were not operated on did
not develop (early) graft thrombosis. Second, two of the
eight patients developing early spontaneous thrombosis
(25%) were not anticipated by displaying a graft flow below
600 ml/min. Thus, it is worthwhile studying how the benefit
from graft flow can be enhanced further. Conceivably, the
predictive value may increase when used in combination with
the course in VP200 results over time rather than single
VP200 measurements. Alternatively, one may consider more
frequent graft flow measurements, but this may be less cost
effective than repetitive VP200 measurements, which can be
obtained easily during each dialysis session. Clearly, prospec-
tive studies are required to resolve this issue.
In conclusion, the present data show that flow measured
using the ultrasound dilution technique are of additional
value to venous pressure measurements in selecting pa-
tients at risk for thrombosis. Further prospective study is
needed to define the optimal frequency and cost effective-
ness of graft flow measurements in the surveillance of
dialysis grafts.
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